Drug firm AstraZeneca Pharma India on Monday reported a 21 percent decline in net profit at Rs 21.05 crore for the quarter ended in December.
The company had posted a net profit of Rs 26.70 crore for the corresponding period of the previous fiscal, AstraZeneca Pharma India said in a BSE filing.
Revenue from operations of the company stood at Rs 200.25 crore for the quarter under consideration.
It was Rs 223.86 crore for the same period a year ago, it added.
Shares of AstraZeneca Pharma India closed at Rs 3,899.40 per scrip on BSE, up 0.11 percent from its previous close.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
